57 related articles for article (PubMed ID: 38447110)
21. Management of Rhabdomyosarcoma in Pediatric Patients.
Rogers TN; Dasgupta R
Surg Oncol Clin N Am; 2021 Apr; 30(2):339-353. PubMed ID: 33706904
[TBL] [Abstract][Full Text] [Related]
22. Disparities in Cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients.
Murphy CC; Lupo PJ; Roth ME; Winick NJ; Pruitt SL
J Natl Cancer Inst; 2021 Aug; 113(8):1074-1083. PubMed ID: 33484568
[TBL] [Abstract][Full Text] [Related]
23. The effect of insurance status on overall survival among children and adolescents with cancer.
Wang X; Ojha RP; Partap S; Johnson KJ
Int J Epidemiol; 2020 Aug; 49(4):1366-1377. PubMed ID: 32572489
[TBL] [Abstract][Full Text] [Related]
24. Global Disparities in Wilms Tumor.
Cunningham ME; Klug TD; Nuchtern JG; Chintagumpala MM; Venkatramani R; Lubega J; Naik-Mathuria BJ
J Surg Res; 2020 Mar; 247():34-51. PubMed ID: 31810638
[TBL] [Abstract][Full Text] [Related]
25. Medicaid Patients Have Greater Difficulty Scheduling Health Care Appointments Compared With Private Insurance Patients: A Meta-Analysis.
Hsiang WR; Lukasiewicz A; Gentry M; Kim CY; Leslie MP; Pelker R; Forman HP; Wiznia DH
Inquiry; 2019; 56():46958019838118. PubMed ID: 30947608
[TBL] [Abstract][Full Text] [Related]
26. Update on neuroblastoma.
Newman EA; Abdessalam S; Aldrink JH; Austin M; Heaton TE; Bruny J; Ehrlich P; Dasgupta R; Baertschiger RM; Lautz TB; Rhee DS; Langham MR; Malek MM; Meyers RL; Nathan JD; Weil BR; Polites S; Madonna MB;
J Pediatr Surg; 2019 Mar; 54(3):383-389. PubMed ID: 30305231
[TBL] [Abstract][Full Text] [Related]
27. Socioeconomics, race, and ethnicity in childhood cancer survival: Accessing and addressing root causes of disparities.
Colton MD; Hawkins M; Goulding D; Cockburn M; Green AL
Cancer; 2018 Oct; 124(20):3975-3978. PubMed ID: 30125347
[No Abstract] [Full Text] [Related]
28. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?
Kehm RD; Spector LG; Poynter JN; Vock DM; Altekruse SF; Osypuk TL
Cancer; 2018 Oct; 124(20):4090-4097. PubMed ID: 30125340
[TBL] [Abstract][Full Text] [Related]
29. Explaining time elapsed prior to cancer diagnosis: patients' perspectives.
Brousselle A; Breton M; Benhadj L; Tremblay D; Provost S; Roberge D; Pineault R; Tousignant P
BMC Health Serv Res; 2017 Jun; 17(1):448. PubMed ID: 28659143
[TBL] [Abstract][Full Text] [Related]
30. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
31. The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study.
Ferrari A; Lo Vullo S; Giardiello D; Veneroni L; Magni C; Clerici CA; Chiaravalli S; Casanova M; Luksch R; Terenziani M; Spreafico F; Meazza C; Catania S; Schiavello E; Biassoni V; Podda M; Bergamaschi L; Puma N; Massimino M; Mariani L
Pediatr Blood Cancer; 2016 Mar; 63(3):479-85. PubMed ID: 26797893
[TBL] [Abstract][Full Text] [Related]
32. Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma.
Truong B; Green AL; Friedrich P; Ribeiro KB; Rodriguez-Galindo C
JAMA Pediatr; 2015 Dec; 169(12):1096-104. PubMed ID: 26436436
[TBL] [Abstract][Full Text] [Related]
33. Health disparities are important determinants of outcome for children with solid tumor malignancies.
Austin MT; Nguyen H; Eberth JM; Chang Y; Heczey A; Hughes DP; Lally KP; Elting LS
J Pediatr Surg; 2015 Jan; 50(1):161-6. PubMed ID: 25598116
[TBL] [Abstract][Full Text] [Related]
34. Investigating the Impact of Tumor Biology and Social Determinants on Time to Diagnosis and Stage at Presentation of Wilms Tumor.
Collins A; Molina Kuna E; Anderson-Mellies A; Cost C; Green AL
J Pediatr Hematol Oncol; 2024 Apr; 46(3):147-153. PubMed ID: 38447110
[TBL] [Abstract][Full Text] [Related]
35. New approaches to risk stratification for Wilms tumor.
Nelson MV; van den Heuvel-Eibrink MM; Graf N; Dome JS
Curr Opin Pediatr; 2021 Feb; 33(1):40-48. PubMed ID: 33394739
[TBL] [Abstract][Full Text] [Related]
36. Wilms' tumor in horseshoe kidney: presentation due to ureteropelvic junction obstruction.
Nirgiotis JG; Black CT; Sherman JO
J Surg Oncol; 1991 Nov; 48(3):210-2. PubMed ID: 1658496
[TBL] [Abstract][Full Text] [Related]
37. Clinical presentation of rhabdoid tumors of the kidney.
Amar AM; Tomlinson G; Green DM; Breslow NE; de Alarcon PA
J Pediatr Hematol Oncol; 2001 Feb; 23(2):105-8. PubMed ID: 11216700
[TBL] [Abstract][Full Text] [Related]
38. Wilms Tumor: Challenges and Newcomers in Prognosis.
Parsons LN
Surg Pathol Clin; 2020 Dec; 13(4):683-693. PubMed ID: 33183727
[TBL] [Abstract][Full Text] [Related]
39. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.
Dome JS; Graf N; Geller JI; Fernandez CV; Mullen EA; Spreafico F; Van den Heuvel-Eibrink M; Pritchard-Jones K
J Clin Oncol; 2015 Sep; 33(27):2999-3007. PubMed ID: 26304882
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
